Coagulation Disturbances in COVID-19 Septic Patients

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Coagulation DisorderCOVID 19 Associated CoagulopathySepsisSeptic Shock
Interventions
DIAGNOSTIC_TEST

CAC in septic patients

"Data collected included demographic parameters, comorbidities, vasopressors requirement, laboratory findings, in-hospital mortality scoring and diagnostic colagulation scores. Demographic parameters were taken on the day of admission, all other variables were taken on the day of admission to the ICU and on the day of initiation of invasive mechanical ventilation or on the day of discharge from the ICU.~Demographic parameters included age and sex of the patient, followed by comorbidities which was marked with Yes or No on the day of admission in the ICU. Mortality was assessed according to the qSOFA score and vasopressor requirements on the day of admission and on the day of initation of invasive mechanical ventilation or on the day of discharge. Laboratory analysis included analysis of platelets, neutrophils, lymphocytes, PCT, CRP, fibrinogen, D-dimer on the day of admission and on the day of initation of invasive mechanical ventilation or on the day of discharge."

Trial Locations (1)

72000

Cantonal Hospital, Zenica

All Listed Sponsors
lead

Cantonal Hospital Zenica

OTHER

NCT05496816 - Coagulation Disturbances in COVID-19 Septic Patients | Biotech Hunter | Biotech Hunter